drugset / Trial / NCT07354100
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
Timeline
- Start
- 2026-12-15
- Primary completion
- 2029-04-13
- Completion
- 2029-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactulose | Other / unclassified | 10 mg | — |
| Subject | Lactulose | Other / unclassified | 10 g | — |